YZ
Yanan Zhu Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
37
Avg Return
Past Year
Past Year
2.8%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
50%
Neutral
50%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $25 |
73%
upside
| 1 | -5.3% |
0
%
| 11 Mar ‘26 1 month ago |
|
|
|
Overweight
Upgraded
| $60 |
241%
upside
| 2 | -20% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
|
Equal-Weight
Maintained
| $15 |
0%
upside
| 1 | +29% |
0
%
| 3 Mar ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $38 |
76%
upside
| 1 | -11% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Equal-Weight
Downgraded
| $115 |
0%
downside
| 1 | – |
–
| 23 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $50 |
32%
downside
| 1 | +16% |
0
%
| 20 Feb ‘26 1 month ago |
|
|
|
Equal-Weight
Downgraded
| $58 |
0%
downside
| 1 | +78% |
0
%
| 20 Jan ‘26 2 months ago |
|